BioSpace News Archive

Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX); or a global innovator in drug delivery platforms, today announced that it intends to effect a reverse stock split of its common stock effective as of 4:30 pm EST on January 11, 2021

Theralase® Technologies Inc., a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers, announces that the Company proposes to extend the expiry date of 4,095,157 share purchase warrants, all of which are exercisable at $0.50 per share.

With the presence of a number of large-, medium-, and small-scale vendors, the global bioactive wound management market demonstrates a competitive and fragmented business landscape, finds a new research study by Transparency Market Research.

Despite featuring a largely fragmented vendor landscape, the global market for membrane separation witnesses a strong grasp of large players operating internationally, notes a recent market research report by Transparency Market Research.

Accuray Incorporated will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the market close on Wednesday January 27, 2021.

OraSure Technologies, Inc. announced that its 2021 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT on Tuesday, May 18, 2021.

AiCuris Anti-infective Cures GmbH, a leading company in the discovery and development of drugs against infectious diseases, today announced that Dr. Holger Zimmermann, CEO of AiCuris, will present at the 39th Annual J.P. Morgan Healthcare Conference (11-14 Jan., 2021) on Thursday, January 14, 2021 at 08:05 am to 08:30 am Eastern Time (02:05 pm to 02:30 pm Central European Time).

Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020. • Consolidated gross sales across all locations during November 2020 totaled $3.4 million, representing a 6.3% year-over-year growth when compared with November 2019. • Prescriptions filled during November came in at appr

Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that David Hung , M.D., founder, president and chief executive officer, will present virtually at the 39 th Annual J.P. Morgan Healthcare Conference on Jan

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 5, 2021 at 8:30 a.m. ET . A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET .